Setting the threshold at the 95th percentile of healthy controls, elevated levels of BAFF were found in 24% of patients with PAPS as compared with 40% in patients with SLE (with or without APS) [56]. This evidence concerns the gene TNFSF13B and autoimmune polyendocrinopathy.